With the school year starting and office reopening plans shifting, many people are unsure of what activities they should be comfortable doing and what they should avoid in the face of the delta variant. Instead of asking experts what other people should do, this week we look at what decisions those ... READ MORE >
5 things to know in life sciences: Week of August 9
With eyes on infrastructure policymaking this week, our roundup takes a look at the components of the Democrats' $3.5 trillion budget framework that could affect the life sciences industry. We also highlight a major investment in surgical robotics, the performance of companies post-merger with a special ... READ MORE >
5 things to know in life sciences: Week of August 2
This week we start with a look at the potential for gene and cell therapy to radically change health care over the coming decade. Although there are few approved drugs using these technologies today, the pipeline of candidates in all phases of clinical studies is full of potential cell and gene therapy ... READ MORE >
5 things to know in life sciences: Week of July 26
This week we highlight the United States Food and Drug Administration’s approval of an insulin biosimilar and their granting of its status as interchangeable with the name brand drug. This promises significant savings for diabetic patients who often face financial hardships because of the cost of care. We ... READ MORE >
5 things to know in life sciences: Week of July 19
This week, we explore an innovative artificial intelligence app used to treat mental health issues. We consider opportunities related to investments in women’s health. We also look at a few pharma giants, including two with a commitment to supply COVID-19 vaccines to Africa and one with a series of big ... READ MORE >
5 things to know in life sciences: Week of July 12
The medical devices sector is booming with activity as evidenced by the 114% year-over-year increase in industry-funded medical devices trial starts for the period of January through May. This week, we explore new technologies contributing to the medical devices boom, including a miniature surgical robot ... READ MORE >
5 things to know in life sciences: Week of June 28
Diabetes effects more than 10% of the U.S. population and brings with it the risk of serious complications, high health care costs and daily difficulties for patients that are afflicted with it. This week we look at the potential of using an old drug to help people with type 1 diabetes as well as the ... READ MORE >
5 things to know in life sciences: Week of June 21
Deep brain stimulation (DBS) is a remarkable tool where a small device is implanted in the body with leads carefully placed at critical spots in the brain. The tool can help manage symptoms of some neurodegenerative diseases. Now, a new generation of devices from Medtronic offers additional tools to ... READ MORE >
5 things to know in life sciences: Week of June 14
Given the high volume of mergers and acquisitions in life sciences, changes in the leadership and focus of the Federal Trade Commission will be closely watched in the coming months as scrutiny could shift to the technology industry. We examine the possible impact below. We also look at CureVac’s ... READ MORE >
5 things to know in life sciences: Week of June 7
The U.S. Food and Drug Administration’s approval of the Alzheimer’s drug, aducanumab, ushered in both a likely blockbuster for developer Biogen and sparked a debate both within the biopharma industry and among health care providers. We also look at a major medical device acquisition, investment in ... READ MORE >